Literature DB >> 4335410

The effect of (+)-catechin on the hepatic level of ATP and the lipid content of liver during experimental steatosis.

A Gajdos, M Gajdos-Tërök, R Horn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4335410     DOI： 10.1016/0006-2952(72)90338-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

Review 1.  ( -)-Epicatechin and cardiometabolic risk factors: a focus on potential mechanisms of action.

Authors:  Ezequiel J Hid; Juana I Mosele; Paula D Prince; Cesar G Fraga; Monica Galleano
Journal:  Pflugers Arch       Date:  2021-11-23       Impact factor: 3.657

2.  Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.

Authors:  S Bar-Meir; Z Halpern; M Gutman; Z Shpirer; M Baratz; D Bass
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

3.  Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen.

Authors:  J J Vallotton; P C Frei
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

4.  Protective effect of (+)cyanidanol-3 in acute liver injury induced by galactosamine or carbon tetrachloride in the rat.

Authors:  D Perrissoud; I Weibel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-07       Impact factor: 3.000

5.  Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trial.

Authors:  J C Colman; M Y Morgan; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1980-11       Impact factor: 23.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.